122 related articles for article (PubMed ID: 15239215)
1. Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells.
Takada M; Hirata K; Ajiki T; Suzuki Y; Kuroda Y
Hepatogastroenterology; 2004; 51(58):928-30. PubMed ID: 15239215
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of RAGE in human pancreatic carcinoma cells.
Takada M; Koizumi T; Toyama H; Suzuki Y; Kuroda Y
Hepatogastroenterology; 2001; 48(42):1577-8. PubMed ID: 11813576
[TBL] [Abstract][Full Text] [Related]
3. Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells.
Hirata K; Takada M; Suzuki Y; Kuroda Y
Hepatogastroenterology; 2003; 50(53):1205-7. PubMed ID: 14571699
[TBL] [Abstract][Full Text] [Related]
4. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.
Ishiguro H; Nakaigawa N; Miyoshi Y; Fujinami K; Kubota Y; Uemura H
Prostate; 2005 Jun; 64(1):92-100. PubMed ID: 15666359
[TBL] [Abstract][Full Text] [Related]
5. S100P promotes pancreatic cancer growth, survival, and invasion.
Arumugam T; Simeone DM; Van Golen K; Logsdon CD
Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
[TBL] [Abstract][Full Text] [Related]
6. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer.
Kuniyasu H; Oue N; Wakikawa A; Shigeishi H; Matsutani N; Kuraoka K; Ito R; Yokozaki H; Yasui W
J Pathol; 2002 Feb; 196(2):163-70. PubMed ID: 11793367
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effects of high mobility group box 1 antisense nucleotide on invasion of human pancreatic cancer cell line PCNA-1].
Huang QX; Wang GB; Sun NF; Wang CY
Ai Zheng; 2004 Sep; 23(9):1036-40. PubMed ID: 15363197
[TBL] [Abstract][Full Text] [Related]
8. Glial cell-derived neurotrophic factor upregulates the expression and activation of matrix metalloproteinase-9 in human pancreatic cancer.
Okada Y; Eibl G; Duffy JP; Reber HA; Hines OJ
Surgery; 2003 Aug; 134(2):293-9. PubMed ID: 12947332
[TBL] [Abstract][Full Text] [Related]
9. Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma.
Bhawal UK; Ozaki Y; Nishimura M; Sugiyama M; Sasahira T; Nomura Y; Sato F; Fujimoto K; Sasaki N; Ikeda MA; Tsuji K; Kuniyasu H; Kato Y
Oncology; 2005; 69(3):246-55. PubMed ID: 16127291
[TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effect of AG490 on invasion and metastasis of human pancreatic cancer cells in vitro].
Huang C; Qiu ZJ; Cao J; Huang KJ; Zhang F; Jiang T; Zhu L; Liu J
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):890-3. PubMed ID: 17533737
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer.
Kuniyasu H; Chihara Y; Takahashi T
Oncol Rep; 2003; 10(2):445-8. PubMed ID: 12579287
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1alpha, 6 regulate the secretion of vascular endothelial growth factor A, C in pancreatic cancer.
Tang RF; Wang SX; Zhang FR; Peng L; Wang SX; Xiao Y; Zhang M
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):460-3. PubMed ID: 16109537
[TBL] [Abstract][Full Text] [Related]
13. Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.
Lubbe WJ; Zhou ZY; Fu W; Zuzga D; Schulz S; Fridman R; Muschel RJ; Waldman SA; Pitari GM
Clin Cancer Res; 2006 Mar; 12(6):1876-82. PubMed ID: 16551873
[TBL] [Abstract][Full Text] [Related]
14. Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells.
Kuwada Y; Sasaki T; Morinaka K; Kitadai Y; Mukaida N; Chayama K
Int J Oncol; 2003 Apr; 22(4):765-71. PubMed ID: 12632066
[TBL] [Abstract][Full Text] [Related]
15. Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowth.
Wang L; Li S; Jungalwala FB
J Neurosci Res; 2008 May; 86(6):1254-66. PubMed ID: 18058943
[TBL] [Abstract][Full Text] [Related]
16. Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration.
Chou DK; Zhang J; Smith FI; McCaffery P; Jungalwala FB
J Neurochem; 2004 Sep; 90(6):1389-401. PubMed ID: 15341523
[TBL] [Abstract][Full Text] [Related]
17. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
[TBL] [Abstract][Full Text] [Related]
18. Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression.
Harashima A; Yamamoto Y; Cheng C; Tsuneyama K; Myint KM; Takeuchi A; Yoshimura K; Li H; Watanabe T; Takasawa S; Okamoto H; Yonekura H; Yamamoto H
Biochem J; 2006 May; 396(1):109-15. PubMed ID: 16503878
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells.
Chen J; Huang L; Song M; Yu S; Gao P; Jing J
J Cardiovasc Pharmacol; 2009 May; 53(5):359-67. PubMed ID: 19276989
[TBL] [Abstract][Full Text] [Related]
20. Age associated changes of AGE-receptor expression: RAGE upregulation is associated with human heart dysfunction.
Simm A; Casselmann C; Schubert A; Hofmann S; Reimann A; Silber RE
Exp Gerontol; 2004 Mar; 39(3):407-13. PubMed ID: 15036400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]